product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
7064/50
catalog :
7064/50
quantity :
50 mg
price :
292 USD
more info or order :
citations: 3
Reference
Lee H, Lee J, Yang M, Kim Y, Hong S, Kim J, et al. Endothelial cell-derived stem cell factor promotes lipid accumulation through c-Kit-mediated increase of lipogenic enzymes in brown adipocytes. Nat Commun. 2023;14:2754 pubmed publisher
Hui C, Wu W, LEUNG S. Interleukins 4 and 21 Protect Anti-IgM Induced Cell Death in Ramos B Cells: Implication for Autoimmune Diseases. Front Immunol. 2022;13:919854 pubmed publisher
Tang Q, Sousa J, Echeverria D, Fan X, Hsueh Y, Afshari K, et al. RNAi-based modulation of IFN-γ signaling in skin. Mol Ther. 2022;30:2709-2721 pubmed publisher
image
image 1 :
Tocris Bioscience 7064/50 image 1
Cat.No. 7064 - Ruxolitinib C17H18N6 CAS No. 941678-49-5
product information
master code :
7064
SKU :
7064/50
product name :
Ruxolitinib
unit size :
50 mg
description :
Potent and selective JAK1/JAK2 inhibitor; orally bioavailable
target :
JAK Kinase Inhibitors
category :
Small Molecules
purity :
98%
observed molecular weight :
306.37
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
Ruxolitinib is a potent and selective JAK1/2 inhibitor (IC50 values are 3.3 and 2.8 nM, respectively). Exhibits selectivity for JAK1/2 over Tyk2 and JAK3 (~6-fold and 130-fold, respectively). Exhibits no significant inhibition against a commercial panel of 26 additional kinases. Inhibits JAK2V617F-mediated signaling and proliferation in Ba/F3 cells and HEL cells. Increases survival rates in a JAK2V617F-driven myeloproliferative neoplasm mouse model. Ruxolitinib has been identified as targeting human host proteins that interact with SARS-CoV-2. The compound can also be used in protocols for the chemical reprogramming of somatic cells to iPSCs. Orally bioavailable. . Phosphate salt (Cat. No. 7048) also available.
top caption :
Potent and selective JAK1/JAK2 inhibitor; orally bioavailable
extended description :
Potent and selective JAK1/JAK2 inhibitor; orally bioavailable
chemical name text :
(3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
formula :
C17H18N6
formula text :
C17H18N6
cas num :
941678-49-5
USD :
292 USD
product details :
Potent and selective JAK1/JAK2 inhibitor; orally bioavailable
alt names :
INCB018424
storage :
Store at -20░C
more info or order :
company information
Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com
800-343-7475
headquarters: UK